Comparison of Pain Perception in A Group of Pediatric Patients Undergoing Maxillary Primary Molar Extraction Using A Novel Anesthetic Device Versus Traditional Infiltration

NANot yet recruitingINTERVENTIONAL
Enrollment

2

Participants

Timeline

Start Date

August 18, 2025

Primary Completion Date

August 18, 2025

Study Completion Date

September 18, 2026

Conditions
PainExtraction, Tooth
Interventions
DEVICE

SleeperOne 5

A computerized local anesthetic delivery system (manufactured by Dental Hi-Tec, France) designed to minimize pain perception in children during dental procedures by controlling the pressure and flow rate of anesthetic injection. It will be used to deliver 3% mepivacaine (Mepecaine-L®, Alexandria Co. for Pharmaceuticals, Egypt) during maxillary primary molar extraction in pediatric patients.

PROCEDURE

(Conventional Infiltration Anesthesia)

Local anesthetic solution (3% mepivacaine with no vasoconstrictor), manufactured by Alexandria Co. for Pharmaceuticals, Egypt. It will be administered using a 30-gauge short dental needle and standard dental syringe for conventional infiltration anesthesia during primary maxillary molar extraction in pediatric patients.

All Listed Sponsors
lead

Aya Hesham ElSayed Mohamed ElTanahy

OTHER

NCT07124052 - Comparison of Pain Perception in A Group of Pediatric Patients Undergoing Maxillary Primary Molar Extraction Using A Novel Anesthetic Device Versus Traditional Infiltration | Biotech Hunter | Biotech Hunter